Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Carbon-templated conductive oxide supports for oxygen evolution catalysis.

Hufnagel AG, Häringer S, Beetz M, Böller B, Fattakhova-Rohlfing D, Bein T.

Nanoscale. 2019 Aug 1;11(30):14285-14293. doi: 10.1039/c9nr03013a.

PMID:
31317996
2.

Enhanced Electric Dipole Strength for the Weakly Bound States in ^{27}Ne.

Loelius C, Kobayashi N, Iwasaki H, Bazin D, Belarge J, Bender PC, Brown BA, Elder R, Elman B, Gade A, Grinder M, Heil S, Hufnagel A, Longfellow B, Lunderberg E, Mathy M, Otsuka T, Petri M, Syndikus I, Tsunoda N, Weisshaar D, Whitmore K.

Phys Rev Lett. 2018 Dec 28;121(26):262501. doi: 10.1103/PhysRevLett.121.262501.

PMID:
30636164
3.

The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.

Appenzeller S, Gesierich A, Thiem A, Hufnagel A, Jessen C, Kneitz H, Regensburger M, Schmidt C, Zirkenbach V, Bischler T, Schilling B, Siedel C, Goebeler ME, Houben R, Schrama D, Gehrig A, Rost S, Maurus K, Bargou R, Rosenwald A, Schartl M, Goebeler M, Meierjohann S.

Cancer. 2019 Feb 15;125(4):586-600. doi: 10.1002/cncr.31843. Epub 2018 Dec 18.

PMID:
30561760
4.

BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1.

Grimm J, Hufnagel A, Wobser M, Borst A, Haferkamp S, Houben R, Meierjohann S.

Oncogenesis. 2018 Sep 20;7(9):71. doi: 10.1038/s41389-018-0082-2.

5.

Solvatochromic covalent organic frameworks.

Ascherl L, Evans EW, Hennemann M, Di Nuzzo D, Hufnagel AG, Beetz M, Friend RH, Clark T, Bein T, Auras F.

Nat Commun. 2018 Sep 18;9(1):3802. doi: 10.1038/s41467-018-06161-w.

6.

Influence of Fermi Level Alignment with Tin Oxide on the Hysteresis of Perovskite Solar Cells.

Aygüler MF, Hufnagel AG, Rieder P, Wussler M, Jaegermann W, Bein T, Dyakonov V, Petrus ML, Baumann A, Docampo P.

ACS Appl Mater Interfaces. 2018 Apr 11;10(14):11414-11419. doi: 10.1021/acsami.8b00990. Epub 2018 Mar 28.

PMID:
29557162
7.

Quasifree (p, 2p) Reactions on Oxygen Isotopes: Observation of Isospin Independence of the Reduced Single-Particle Strength.

Atar L, Paschalis S, Barbieri C, Bertulani CA, Díaz Fernández P, Holl M, Najafi MA, Panin V, Alvarez-Pol H, Aumann T, Avdeichikov V, Beceiro-Novo S, Bemmerer D, Benlliure J, Boillos JM, Boretzky K, Borge MJG, Caamaño M, Caesar C, Casarejos E, Catford W, Cederkall J, Chartier M, Chulkov L, Cortina-Gil D, Cravo E, Crespo R, Dillmann I, Elekes Z, Enders J, Ershova O, Estrade A, Farinon F, Fraile LM, Freer M, Galaviz Redondo D, Geissel H, Gernhäuser R, Golubev P, Göbel K, Hagdahl J, Heftrich T, Heil M, Heine M, Heinz A, Henriques A, Hufnagel A, Ignatov A, Johansson HT, Jonson B, Kahlbow J, Kalantar-Nayestanaki N, Kanungo R, Kelic-Heil A, Knyazev A, Kröll T, Kurz N, Labiche M, Langer C, Le Bleis T, Lemmon R, Lindberg S, Machado J, Marganiec-Gałązka J, Movsesyan A, Nacher E, Nikolskii EY, Nilsson T, Nociforo C, Perea A, Petri M, Pietri S, Plag R, Reifarth R, Ribeiro G, Rigollet C, Rossi DM, Röder M, Savran D, Scheit H, Simon H, Sorlin O, Syndikus I, Taylor JT, Tengblad O, Thies R, Togano Y, Vandebrouck M, Velho P, Volkov V, Wagner A, Wamers F, Weick H, Wheldon C, Wilson GL, Winfield JS, Woods P, Yakorev D, Zhukov M, Zilges A, Zuber K; R^{3}B Collaboration.

Phys Rev Lett. 2018 Feb 2;120(5):052501. doi: 10.1103/PhysRevLett.120.052501.

PMID:
29481189
8.

The interaction network of the YidC insertase with the SecYEG translocon, SRP and the SRP receptor FtsY.

Petriman NA, Jauß B, Hufnagel A, Franz L, Sachelaru I, Drepper F, Warscheid B, Koch HG.

Sci Rep. 2018 Jan 12;8(1):578. doi: 10.1038/s41598-017-19019-w.

9.

Oriented Films of Conjugated 2D Covalent Organic Frameworks as Photocathodes for Water Splitting.

Sick T, Hufnagel AG, Kampmann J, Kondofersky I, Calik M, Rotter JM, Evans A, Döblinger M, Herbert S, Peters K, Böhm D, Knochel P, Medina DD, Fattakhova-Rohlfing D, Bein T.

J Am Chem Soc. 2018 Feb 14;140(6):2085-2092. doi: 10.1021/jacs.7b06081. Epub 2018 Jan 29.

10.

The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.

Maurus K, Hufnagel A, Geiger F, Graf S, Berking C, Heinemann A, Paschen A, Kneitz S, Stigloher C, Geissinger E, Otto C, Bosserhoff A, Schartl M, Meierjohann S.

Oncogene. 2017 Sep 7;36(36):5110-5121. doi: 10.1038/onc.2017.135. Epub 2017 May 8.

PMID:
28481878
11.

Recovery from alcohol dependence: Do smoking indicators predict abstinence?

Hufnagel A, Frick U, Ridinger M, Wodarz N.

Am J Addict. 2017 Jun;26(4):366-373. doi: 10.1111/ajad.12535. Epub 2017 Apr 4.

PMID:
28376287
12.

Control of Perovskite Crystal Growth by Methylammonium Lead Chloride Templating.

Binek A, Grill I, Huber N, Peters K, Hufnagel AG, Handloser M, Docampo P, Hartschuh A, Bein T.

Chem Asian J. 2016 Apr 20;11(8):1199-204. doi: 10.1002/asia.201501379. Epub 2016 Mar 1.

PMID:
26928877
13.

Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling.

Schmitt A, Schmitz W, Hufnagel A, Schartl M, Meierjohann S.

Biochem J. 2015 Oct 15;471(2):267-79. doi: 10.1042/BJ20141204. Epub 2015 Aug 18.

PMID:
26285655
14.

In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.

Leikam C, Hufnagel AL, Otto C, Murphy DJ, Mühling B, Kneitz S, Nanda I, Schmid M, Wagner TU, Haferkamp S, Bröcker EB, Schartl M, Meierjohann S.

Cell Death Dis. 2015 Apr 2;6:e1711. doi: 10.1038/cddis.2015.71.

15.

The MAPK pathway as an apoptosis enhancer in melanoma.

Haydn JM, Hufnagel A, Grimm J, Maurus K, Schartl M, Meierjohann S.

Oncotarget. 2014 Jul 15;5(13):5040-53.

16.

Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.

Dambach H, Hinkerohe D, Prochnow N, Stienen MN, Moinfar Z, Haase CG, Hufnagel A, Faustmann PM.

Epilepsia. 2014 Jan;55(1):184-92. doi: 10.1111/epi.12473. Epub 2013 Dec 2.

17.

Cystathionase mediates senescence evasion in melanocytes and melanoma cells.

Leikam C, Hufnagel A, Walz S, Kneitz S, Fekete A, Müller MJ, Eilers M, Schartl M, Meierjohann S.

Oncogene. 2014 Feb 6;33(6):771-82. doi: 10.1038/onc.2012.641. Epub 2013 Jan 28.

PMID:
23353821
18.

Vemurafenib induces senescence features in melanoma cells.

Haferkamp S, Borst A, Adam C, Becker TM, Motschenbacher S, Windhövel S, Hufnagel AL, Houben R, Meierjohann S.

J Invest Dermatol. 2013 Jun;133(6):1601-9. doi: 10.1038/jid.2013.6. Epub 2013 Feb 14.

19.

Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.

Hufnagel A, Ben-Menachem E, Gabbai AA, Falcão A, Almeida L, Soares-da-Silva P.

Epilepsy Res. 2013 Feb;103(2-3):262-9. doi: 10.1016/j.eplepsyres.2012.07.014. Epub 2012 Aug 4.

PMID:
22871333
20.

Long-term assessment of topiramate for epilepsy: an open-label, single-arm, multicentre, prospective study in a naturalistic setting.

Hufnagel A, Kowalik A, Rettig K, Schreiner A, Schäuble B; TOP-GER-11 Investigators.

Clin Drug Investig. 2011 Nov 1;31(11):779-90. doi: 10.2165/11593850-000000000-00000.

PMID:
21967069
21.

MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation.

Meierjohann S, Hufnagel A, Wende E, Kleinschmidt MA, Wolf K, Friedl P, Gaubatz S, Schartl M.

Mol Cancer. 2010 Jul 28;9:201. doi: 10.1186/1476-4598-9-201.

22.

Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.

Ben-Menachem E, Gabbai AA, Hufnagel A, Maia J, Almeida L, Soares-da-Silva P.

Epilepsy Res. 2010 May;89(2-3):278-85. doi: 10.1016/j.eplepsyres.2010.01.014. Epub 2010 Mar 17.

PMID:
20299189
23.

Substitution of anticonvulsant drugs.

Steinhoff BJ, Runge U, Witte OW, Stefan H, Hufnagel A, Mayer T, Krämer G.

Ther Clin Risk Manag. 2009 Jun;5(3):449-57. Epub 2009 Jun 22.

24.

Interhemispheric transfer of predictive force control during grasping in cerebellar disorders.

Nowak DA, Hufnagel A, Ameli M, Timmann D, Hermsdörfer J.

Cerebellum. 2009 Jun;8(2):108-15. doi: 10.1007/s12311-008-0081-5. Epub 2008 Dec 4.

PMID:
19052829
25.

Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence.

Leikam C, Hufnagel A, Schartl M, Meierjohann S.

Oncogene. 2008 Nov 27;27(56):7070-82. doi: 10.1038/onc.2008.323. Epub 2008 Sep 22.

PMID:
18806824
26.

The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 procedures.

Haag A, Knake S, Hamer HM, Boesebeck F, Freitag H, Schulz R, Baum P, Helmstaedter C, Wellmer J, Urbach H, Hopp P, Mayer T, Hufnagel A, Jokeit H, Lerche H, Uttner I, Meencke HJ, Meierkord H, Pauli E, Runge U, Saar J, Trinka E, Benke T, Vulliemoz S, Wiegand G, Stephani U, Wieser HG, Rating D, Werhahn K, Noachtar S, Schulze-Bonhage A, Wagner K, Alpherts WC, Boas Wv, Rosenow F; Arbeitsgemeinschaft für Prächirurgische Epilepsiediagnostik und Operative Epilepsietherapie e.V.

Epilepsy Behav. 2008 Jul;13(1):83-9. doi: 10.1016/j.yebeh.2008.02.012. Epub 2008 Mar 20. Review.

PMID:
18358786
27.

Low hospital admission rates following MDMA (Ecstasy) intake in Essen (Germany).

Scherbaum N, Bonnet U, Schifano F, Birkemeyer W, Hufnagel A, Schmitz D, Sipal SC, Wiemer P, Wurthmann C.

Am J Addict. 2007 Sep-Oct;16(5):428-9. No abstract available.

PMID:
17882618
28.

Saccade induced cortical activation in patients with post-stroke visual field defects.

Nelles G, de Greiff A, Pscherer A, Stude P, Forsting M, Hufnagel A, Gerhard H, Esser J, Diener HC.

J Neurol. 2007 Sep;254(9):1244-52. Epub 2007 Aug 11.

PMID:
17694385
29.

Early diffusion-weighted MRI predicts regional neuronal damage in generalized status epilepticus in rats treated with diazepam.

Engelhorn T, Weise J, Hammen T, Bluemcke I, Hufnagel A, Doerfler A.

Neurosci Lett. 2007 May 7;417(3):275-80. Epub 2007 Mar 2.

PMID:
17367928
30.

Monitoring of acute generalized status epilepticus using multilocal diffusion MR imaging: early prediction of regional neuronal damage.

Engelhorn T, Hufnagel A, Weise J, Baehr M, Doerfler A.

AJNR Am J Neuroradiol. 2007 Feb;28(2):321-7.

31.

[Diagnostics and treatment of a first-time epileptic seizure].

Hufnagel A.

Fortschr Neurol Psychiatr. 2006 Dec;74(12):732-5; quiz 736-8. German. No abstract available.

PMID:
17167731
32.

Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study.

Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schöllhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M.

Brain. 2006 Aug;129(Pt 8):2047-60. Epub 2006 Jun 30.

PMID:
16815873
33.

Brain perfusion following single seizures.

Leonhardt G, de Greiff A, Weber J, Ludwig T, Wiedemayer H, Forsting M, Hufnagel A.

Epilepsia. 2005 Dec;46(12):1943-9.

34.

MRI changes associated with partial status epilepticus.

Kavuk I, Hufnagel A, Agelink MW, Limmroth V, Dörfler A, Sayar K, Selekler M, Diener HC, Koeppen S.

Eur J Med Res. 2005 Jun 22;10(6):243-6. Review.

PMID:
16033713
35.
36.
37.

Levetiracetam inhibits Na+-dependent Cl-/HCO3- exchange of adult hippocampal CA3 neurons from guinea-pigs.

Leniger T, Thöne J, Bonnet U, Hufnagel A, Bingmann D, Wiemann M.

Br J Pharmacol. 2004 Aug;142(7):1073-80. Epub 2004 Jul 12.

38.

[Altered cerebral excitability and spreading depression. Causes for the comorbidity of epilepsy and migraine?].

Leniger T, Diener HC, Hufnagel A.

Nervenarzt. 2003 Oct;74(10):869-74. Epub 2003 Jun 18. German.

PMID:
14551691
39.

A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.

Leniger T, Kananura C, Hufnagel A, Bertrand S, Bertrand D, Steinlein OK.

Epilepsia. 2003 Jul;44(7):981-5.

40.

Clinical characteristics of patients with comorbidity of migraine and epilepsy.

Leniger T, von den Driesch S, Isbruch K, Diener HC, Hufnagel A.

Headache. 2003 Jun;43(6):672-7.

PMID:
12786928
41.

Presurgical evaluation of epilepsy by brain diffusion: MR-detected effects of flumazenil on the epileptogenic focus.

Konermann S, Marks S, Ludwig T, Weber J, de Greiff A, Dörfler A, Leonhardt G, Wiedemayer H, Diener HC, Hufnagel A.

Epilepsia. 2003 Mar;44(3):399-407.

42.

Brain diffusion after single seizures.

Hufnagel A, Weber J, Marks S, Ludwig T, De Greiff A, Leonhardt G, Widmann G, Stolke D, Forsting M.

Epilepsia. 2003 Jan;44(1):54-63.

43.

Brain diffusion during hyperventilation: diffusion-weighted MR-monitoring in patients with temporal lobe epilepsy and in healthy volunteers.

Leonhardt G, de Greiff A, Marks S, Ludwig T, Doerfler A, Forsting M, Konermann S, Hufnagel A.

Epilepsy Res. 2002 Oct;51(3):269-78.

PMID:
12399077
44.

Clinical outcome and neuropsychological deficits after right decompressive hemicraniectomy in MCA infarction.

Leonhardt G, Wilhelm H, Doerfler A, Ehrenfeld CE, Schoch B, Rauhut F, Hufnagel A, Diener HC.

J Neurol. 2002 Oct;249(10):1433-40.

PMID:
12382162
45.

Valproate acidifies hippocampal CA3-neurons--a novel mode of action.

Bonnet U, Bingmann D, Leniger T, Scherbaum N, Widman G, Hufnagel A, Wiemann M.

Eur Neuropsychopharmacol. 2002 Aug;12(4):279-85.

PMID:
12126866
46.

Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons.

Leniger T, Wiemann M, Bingmann D, Widman G, Hufnagel A, Bonnet U.

Epilepsia. 2002 May;43(5):469-74.

47.

Cortical activation in patients with functional hemispherectomy.

Leonhardt G, Bingel U, Spiekermann G, Kurthen M, Müller S, Hufnagel A.

J Neurol. 2001 Oct;248(10):881-8.

PMID:
11697526
48.

Seizure-associated headache in epilepsy.

Leniger T, Isbruch K, von den Driesch S, Diener HC, Hufnagel A.

Epilepsia. 2001 Sep;42(9):1176-9.

49.

ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery.

Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, Sperling MR, Lüders H, Pedley TA; Commission on Neurosurgery of the International League Against Epilepsy (ILAE).

Epilepsia. 2001 Feb;42(2):282-6. No abstract available.

Supplemental Content

Loading ...
Support Center